Disseminated Peritoneal Leiomyomatosis Responds to Systemic Chemotherapy

被引:21
|
作者
Lin, Y-C. [1 ]
Wei, L-H. [1 ,2 ]
Shun, C-T. [3 ]
Cheng, A-L. [1 ,4 ,5 ]
Hsu, C-H. [1 ,5 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Oncol, Taipei 100, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Obstet & Gynecol, Taipei 100, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan
[4] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[5] Natl Taiwan Univ, Coll Med, Canc Res Ctr, Taipei 10764, Taiwan
关键词
Leiomyomatosis peritonealis disseminata; Metastasis; Chemotherapy; Doxorubicin; Dacarbazine; BENIGN METASTASIZING LEIOMYOMA;
D O I
10.1159/000178761
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Leiomyomatosis peritonealis disseminata (LPD) is a rare disease entity characterized by multiple peritoneal tumors composed of benign but proliferative smooth muscle cells. Surgery is the mainstay treatment for LPD. We present a 50-year- old woman who had previously undergone several surgical resections including bilateral oophorectomy for recurrent LPD. Because of progressive tumors in the peritoneum and metastatic tumors in the liver and lungs, systemic chemotherapy with doxorubicin and dacarbazine was prescribed. Objective tumor response was achieved and sustained for 1 year. This case presentation suggests that systemic chemotherapy may be considered as a treatment option for LPD patients developing unresectable or metastatic disease. Copyright (C) 2008 S. Karger AG, Basel
引用
收藏
页码:55 / 58
页数:4
相关论文
共 50 条
  • [31] Systemic Therapy Options for Peritoneal Mesothelioma
    Tanvetyanon, Tawee
    Simon, George R.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (08):
  • [32] Systemic chemotherapy of liver tumors
    Johnson, PJ
    SEMINARS IN SURGICAL ONCOLOGY, 2000, 19 (02): : 116 - 124
  • [33] Sebaceous carcinoma and systemic chemotherapy
    Joshi, Poonam
    joshi, Amit
    Norohna, Vanita
    Prabhash, Kumar
    Kane, Subhdha
    D'cruz, Anil K.
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2012, 33 (04) : 239 - 241
  • [34] Effects of systemic chemotherapy on the liver
    Ramadori, Giuliano
    Cameron, Silke
    ANNALS OF HEPATOLOGY, 2010, 9 (02) : 133 - 143
  • [35] Systemic chemotherapy for pancreatic cancer
    Okusaka, T
    Kosuge, T
    PANCREAS, 2004, 28 (03) : 301 - 304
  • [36] SYSTEMIC CHEMOTHERAPY OF CUTANEOUS NEOPLASIA
    REINHOLD, U
    ONKOLOGIE, 1991, 14 (02): : 137 - &
  • [37] Establishment of a Mouse Ovarian Cancer and Peritoneal Metastasis Model to Study Intraperitoneal Chemotherapy
    Rezniczek, Guenther A.
    Buggisch, Jonathan
    Sobilo, Julien
    Launay, Alexandre
    Lerondel, Stephanie
    Le Pape, Alain
    Ouaissi, Mehdi
    Goehler, Daniel
    Senkal, Metin
    Giger-Pabst, Urs
    Tempfer, Clemens B.
    CANCERS, 2020, 12 (12) : 1 - 13
  • [38] Utilization of perioperative systemic chemotherapy in upper tract urothelial carcinoma
    Gin, Greg E.
    Ruel, Nora H.
    Kardos, Steven V.
    Sfakianos, John P.
    Uchio, Edward
    Lau, Clayton S.
    Yuh, Bertram E.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (05) : 192 - 200
  • [39] Chemobrain: is systemic chemotherapy neurotoxic?
    Taillibert, Sophie
    Voillery, Dorothee
    Bernard-Marty, Chantal
    CURRENT OPINION IN ONCOLOGY, 2007, 19 (06) : 623 - 627
  • [40] A pharmacological review on intraperitoneal chemotherapy for peritoneal malignancy
    Yan, Tristan D.
    Cao, Christopher Qian
    Munkholm-Larsen, Stine
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2010, 2 (02) : 109 - 116